Prime medicine unveils strategically focused pipeline

-- prioritizing set of high value programs in core areas of focus; modularity of prime editing platform expected to allow prime medicine to generate follow-on candidates rapidly and efficiently -- -- initial clinical data from phase 1/2 trial in cgd expected in 2025 while advancing wilson's disease program toward expected ind application and/or cta in 1h 2026 --
PRME Ratings Summary
PRME Quant Ranking